Your browser doesn't support javascript.
loading
Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques.
Nelson, Ashley N; Shen, Xiaoying; Vekatayogi, Sravani; Zhang, Shiyu; Ozorowski, Gabriel; Dennis, Maria; Sewall, Leigh M; Milligan, Emma; Davis, Dominique; Cross, Kaitlyn A; Chen, Yue; van Schooten, Jelle; Eudailey, Joshua; Isaac, John; Memon, Saad; Weinbaum, Carolyn; Stanfield-Oakley, Sherry; Byrd, Alliyah; Chutkan, Suni; Berendam, Stella; Cronin, Kenneth; Yasmeen, Anila; Alam, S Munir; LaBranche, Celia C; Rogers, Kenneth; Shirreff, Lisa; Cupo, Albert; Derking, Ronald; Villinger, Francois; Klasse, Per Johan; Ferrari, Guido; Williams, Wilton B; Hudgens, Michael G; Ward, Andrew B; Montefiori, David C; Van Rompay, Koen K A; Wiehe, Kevin; Moore, John P; Sanders, Rogier W; De Paris, Kristina; Permar, Sallie R.
Afiliação
  • Nelson AN; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Shen X; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Vekatayogi S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Zhang S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Dennis M; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Milligan E; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA.
  • Davis D; Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA.
  • Cross KA; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA.
  • Chen Y; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • van Schooten J; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands.
  • Eudailey J; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Isaac J; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Memon S; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Weinbaum C; Department of Pediatrics, Weill Cornell Medicine; New York, NY, USA.
  • Stanfield-Oakley S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Byrd A; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Chutkan S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Berendam S; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Cronin K; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Yasmeen A; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.
  • Alam SM; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • LaBranche CC; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Rogers K; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
  • Shirreff L; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
  • Cupo A; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.
  • Derking R; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands.
  • Villinger F; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
  • Klasse PJ; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA.
  • Ferrari G; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.
  • Williams WB; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Hudgens MG; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Ward AB; Gillings School of Public Health and Center for AIDS Research, University of North Carolina at Chapel Hill; Chapel Hill, NC, USA.
  • Montefiori DC; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Van Rompay KKA; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Wiehe K; California National Primate Research Center, University of California; Davis, CA, USA.
  • Moore JP; Human Vaccine Institute, Duke University Medical Center; Durham, NC, USA.
  • Sanders RW; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.
  • De Paris K; Department of Medical Microbiology, Academic Medical Center; Amsterdam, Netherlands.
  • Permar SR; Department of Microbiology and Immunology, Weill Cornell Medicine; New York, NY, USA.
bioRxiv ; 2023 Nov 11.
Article em En | MEDLINE | ID: mdl-37986885
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos